"Lack of population-specific genomic data is a significant challenge in the field of precision oncology"

Expanding its R&D capabilities to further enhance cancer detection and treatment efficacy, aligning with global efforts to revolutionise oncology care with the world observing World Cancer Day on February 4, Bengaluru-based startup 4baseCare has recently received a significant boost with Infosys investing Rs 8.3 crore to acquire a minority stake in the company. In conjunction with this, BioSpectrum took the opportunity to speak with Hitesh Goswami, Chief Executive Officer (CEO) and Co-Founder, 4baseCare regarding their future plans and advancements in precision oncology.

- Vrushti Kothari

With Infosys investing in 4baseCare, how do you plan to leverage this partnership to scale your operations, enhance technological capabilities, and drive growth?

At 4baseCare, we drive innovation through two core solutions: Genomics and Digital Health. Our Genomics solutions focus on leveraging advanced genomic testing to identify actionable insights for personalised cancer care, while our Digital Health solutions encompass a comprehensive ecosystem designed to support patients and clinicians alike.

This includes everything from a patientcentric app that provides guidance throughout the cancer journey, to sophisticated tools that generate insights for predictive modeling, enabling personalised treatment strategies.

Collaborating with Infosys, a global leader in IT and digital transformation, we are enhancing the digital backbone of 4baseCare. Their expertise enables us to build a data-driven decision platform and develop pioneering solutions like the ClinicoGenomic Digital Twin (CG Twin)—a revolutionary model that integrates clinical and genomic data to create predictive insights for tailored cancer care. Together, we are bridging the gap between data, technology, and precision oncology to empower patients and healthcare providers with innovative, impactful solutions.

Besides this recent partnership, what were some of the other major developments at 4baseCare in 2024?

The year 2024 has been a year of tremendous growth and significant milestones. We raised $6 million in Series A funding led by Yali Capital, which enabled us to set up a genomics lab at Dubai Science Park in partnership with Innovate Life Sciences. We are also preparing to launch labs in the Philippines and Nepal.